Just a listing for easy reference;
RECRUITING: Dose-escalation, Dose-expansion Study of Safety of PBCAR0191 in Patients With r/r NHL and r/r B-cell ALL
https://www.clinicaltrials.gov/study/NCT03666000
RECRUITING: A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) (OASIS)
https://www.clinicaltrials.gov/study/NCT06063317
RECRUITING: A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (MAST)
https://www.clinicaltrials.gov/study/NCT05346484
ACTIVE, NOT RECRUITING: Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) (nextHERIZON)
https://www.clinicaltrials.gov/study/NCT05311176
ACTIVE, NOT RECRUITING: A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
https://www.clinicaltrials.gov/study/NCT04432207
ACTIVE, NOT RECRUITING:A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
https://www.clinicaltrials.gov/study/NCT02795988
ACTIVE, NOT RECRUITING: CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer
https://www.clinicaltrials.gov/study/NCT05081492
Just a listing for easy reference;RECRUITING: Dose-escalation,...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $373.3M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $669.7K | 13.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1074997 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 1209633 | 6 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |